medigraphic.com

2017, Number 4

<< Back Next >>

Rev Mex Anest 2017; 40 (4)

Acute renal insufficiency (IRA) classification, physiopathology, histopathology, clinical picture diagnosis and treatment a logical version

Díaz de León-Ponce MA, Briones-Garduño JC, Carrillo-Esper R, Moreno-Santillán A, Pérez-Calatayud ÁA

Language: Spanish
References: 48
Page: 280-287
PDF size: 269.30 Kb.


ABSTRACT

Since World War II the first description of the IRA was made, nephrologists devoted little time to the study of this syndrome, since it is of great importance with the advent of the dialysis systems of the so-called chronic renal disease, which not only represented the interest of the survival of the chronic renal patient and also the economic importance of the pharmaceutical and dialysis industry and has been increasing for more than three decades the increase of diabetes mellitus and consequently diabetic nephropathy and ARI only represented 2 to 5% of the income to the nephrology services with a high mortality due to the complications that accompanied it, so it was left to the specialists of the intensive care units who have made multiple classifications both for diagnosis and for their therapeutics and with increasingly sophisticated versions to explain their pathophysiology and without understanding the changes which may be present in the renal structures, which delays an effective and timely treatment for greater survival. This article tries to obtain three objectives cost benefit, cost utility and cost effectiveness with a logical version of the syndrome.


REFERENCES

  1. Kellum JA, Bellomo R, Ronco C. Kidney attack. JAMA. 2012;307:2265-2266.

  2. Ronco C, Chawla LS. Kidney attack must be prevented. Nat Rev Nephrol. 2013;9:198-199.

  3. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute Kidney Injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365-3370.

  4. Cerda J, Bagga A, Kher V, Chakravarthi RM. The contrasting characteristics of acute kidney injury in developed and developing countries. Nat Clin Pract Nephrol. 2008;4:138-153.

  5. Lameire NH, Bagga A, Cruz D, Maeseneer J, Endre Z, Kellum J, et al. Acute kidney injury: an increasing global concern. Lancet. 2013;382:170-179.

  6. Li PK, Burdmann EA, Mehta RL; World Kidney Day Steering Committee 2013.. Acute kidney injury: global health alert. Kidney Int. 2013;83:372-376.

  7. Munshi R, Hsu C, Himmelfarb J. Advances in understanding ischemic acute kidney injury. BMC Medicine. 2011;9:11-16.

  8. Cerdá J, Lameire N, Eggers P, Pannu N, Uchino S, Wang H, et al. Epidemiology of acute kidney injury. Clin J Am Soc Nephrol. 2008;3:881-886.

  9. Thakar CV. Perioperative acute kidney injury. Adv Chronic Kidney Dis. 2013;20:67-75.

  10. Singbartl K, Kellum JA. AKI in the ICU: definition, epidemiology, risk-stratification, and outcomes. Kidney Int. 2012;81:819-825.

  11. Srisawat N, Kellum JA. Acute kidney injury: definition, epidemiology, and outcome. Curr Opin Crit Care. 2011;17:548-555.

  12. Díaz de León PMA, Briones GJC, Aristondo MG. Clasificaciones de la insuficiencia renal aguda. Rev Asoc Mex Med Crit y Ter Int. 2014;28:28-31.

  13. Díaz de León PM. Alcaraz TL. Juárez Díaz GN. Pérez CJF. Comparación de las pruebas horarias de la depuración renal contra las de 24 horas en adultos sanos jóvenes. Arch Invest Med (Mex). 1982; 133: 139-143.

  14. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute dialysis quality initiative workgroup: acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:204-212.

  15. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int. 2008;73:538-546.

  16. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.

  17. Zappitelli M, Parikh CR, Akcan-Arikan A, Washburn KK, Moffett BS, Goldstein SL. Ascertainment and epidemiology of acute kidney injury varies with definition interpretation. Clin J Am Soc Nephrol. 2008;3:948-954.

  18. McCullough PA, Shaw AD, Haase M, Bouchard J, Waikar SS, Siew ED, et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol. 2013;182:13-29.

  19. Ronco C, McCullough PA, Chawla LS. Kidney attack versus heart attack: evolution of classification and diagnostic criteria. Lancet. 2013;382:939-940.

  20. Ronco C. Kidney attack: Overdiagnosis of acute kidney injury or comprehensive definition of acute kidney syndromes? Blood Purif. 2013;36:65-68.

  21. Ronco C, Ricci Z. The concept of risk and the value of novel markers of acute kidney injury. Crit Care. 2013;17:117.

  22. Díaz de León PM. Briones GJC. Aristondo MG. Síndrome de insuficiencia renal aguda. México. Ed. Prado. 2015, pp. 43-46.

  23. Díaz de León PM. Insuficiencia renal aguda. México. Ed. Limusa. 1991, pp. 93-94. ISBN 968-18-3978-3981.

  24. Díaz de León PM. Medicina critica México. Ed. Limusa. Noriega. 1993, pp. 369-382.

  25. Ronco C, Kellum JA, Haase M. Subclinical AKI is still AKI. Crit Care. 2012;16:313.

  26. Srisawat N, Hoste EE, Kellum JA. Modern classification of acute kidney injury. Blood Purif. 2010;29:300-307.

  27. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756-766.

  28. Ricci Z, Cruz DN, Ronco C. Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol. 2011;7:201-208.

  29. Talabani B, Zouwail S, Pyart RD, Meran S, Riley SG, Phillips AO. Epidemiology and outcome of community-acquired acute kidney injury. Nephrology (Carlton). 2014;19(5):282-287.

  30. Wen Y, Jiang L, Xu Y, Qian CY, Li SS, Qin TH, et al. China Critical Care Clinical Trial Group (CCCCTG). Prevalence, risk factors, clinical course, and outcome of acute kidney injury in Chinese intensive care units: a prospective cohort study. Chin Med J. 2013;126:4409-4416.

  31. Maccariello E, Soares M, Valente C, Nogueira L, Valença RV, Machado JE et al. RIFLE classification in patients with acute kidney injury in need of renal replacement therapy. Intensive Care Med. 2007;33:597-605.

  32. Molitoris BA, Melnikov VY, Okusa MD, Himmelfarb J. Technology insight: biomarker development in acute kidney injury-what can we anticipate? Nat Clin Pract Nephrol. 2008;4:154-165.

  33. Díaz de León PM. Briones GJC. Aristondo MG. Medicina aguda. México. Ed. Prado. 2ª edición 2014, pp. 260-262.

  34. Meneses CJ, Briones VC, Moreno SA, Amezola CM, Anaya TT, Mujica HM y cols. β2 microglobulina como marcador de IRA en pacientes obstétricas. Rev Asoc Mex Med Crit Ter Int. 2007;XXI:63-66.

  35. Davenport A. Renal replacement therapy in the patient with acute brain injury. Ame J Kidney Dis. 2001;37:457-466.

  36. Parikh CR, Devarajan P. New biomarkers of acute kidney injury. Crit Care Med. 2008;36:159-165.

  37. Schardijn GH, Statius VE. β2 Microglobulin: Its significance in the evaluation of renal function. Kidney Int. 1987;32:635-641.

  38. Miyata T, Jadoul M, Kurokawa K, Ypersele de Strihou ChV. Beta-2 microglobulin in renal disease. J Am Soc Nephrol. 1998;9:1723-1735.

  39. Reichert LJ, Koene RAP, Wetzels JF. Urinary excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy. J Am Soc Nephrol. 1995;6:1666-1669.

  40. Haddad B, Desvaux D, Livingston JC, Barrenger E, Paniel BJ, Sibai BM. Failure of serum beta2-microglobulin levels as an early marker of preeclampsia. Am J Obstet Gynecol. 2000;182:595-598.

  41. Hawkins R. New biomarkers of acute kidney injury and the cardio-renal syndrome. Korean J Lab Med. 2011;31:72-80.

  42. Cruz DN, de Geus HR, Bagshaw SM. Biomarker strategies to predict need for renal replacement therapy in acute kidney injury. Semin Dial. 2011;24:124-131.

  43. Briones GJ, Díaz LP, Loiseau AH, Briones VC. Una nueva prueba de función renal. Rev Asoc Mex Med Crit y Ter Int. 2010;1:30-34.

  44. Díaz de León PM, Briones GJC, Aristondo MG. Síndrome de insuficiencia renal aguda. México. Ed. Prado. 2015, pp. 80-93.

  45. Díaz de León M, Moreno SA, Gonzales DD, Briones GJ. Sepsis severa como causa de falla renal aguda. Nefrología (España). 2006;26:439-444.

  46. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, et al. Intensity of continuous renal-replacement therapy in critically ill patients. The RENAL Replacement Therapy Study Investigators. N Engl J Med. 2009;361:1627-1638.

  47. Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, et al. Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. Intensive Care Med. 2011;37:241-248.

  48. Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, et al. Intensity of renal support in critically ill patients with acute kidney injury. The VA/NIH Acute Renal Failure Trial Network. N Engl J Med. 2008;359:7-20.




2020     |     www.medigraphic.com